Objectives
The primary objective of this study was to determine the percentage of hospitals that provided clinical pharmacy services to their intensive care units (ICU) in Puerto Rico. In addition, the scope and type of clinical pharmacy services provided in the ICU setting were assessed.
Methods
A cross‐sectional survey was developed and distributed via e‐mail to pharmacy directors of Puerto Rico hospitals (n = 56). The survey was sent on two occasions during the month of July 2016. Questions were divided into two categories: practice site information and ICU pharmacy services.
Key findings
A total of 21 survey responses were completed representing 37.5% of Puerto Rico hospitals and 51 ICUs. Pharmacy services to the ICU were mainly from a centralized pharmacy (95.2%). Overall, 42.8% of hospitals reported having some extent of clinical pharmacy services provided to the ICU. Only 4.8% of hospitals indicated having a clinical pharmacist dedicated to ICU for more than 20 h a week. Three hospitals indicated pharmacist had residency training, and two had board certifications. Main fundamental and desirable activities included multidisciplinary rounds, therapeutic interventions and drug information. On average, ICU pharmacists participated in rounds 16.6 ± 7.5 h/week and an average of 6 ± 2.8 h/week staffing.
Conclusions
Based on this survey, critical care clinical pharmacy services in Puerto Rico are insufficient. Additional training in critical care should be promoted among hospital pharmacists in the island. Development of postgraduate critical care training programmes and continuing education seminars in Puerto Rico should also be promoted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.